USPTO serial 77636189
FLARE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jan 17, 2012
- Examiner
- FATHY, DOMINIC
- Law office
- —
What this means
Status 705 means a Madrid-based U.S. registration has accepted Section 71 maintenance and Section 15 incontestability. The U.S. extension is active with strengthened rights. Track next renewal deadlines in TSDR and WIPO records.
Need help with FLARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Beth Israel Deaconess Medical Center, Inc.
Boston, MA
Other trademarks owned by Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc.
Boston, MA
Other trademarks owned by Beth Israel Deaconess Medical Center, Inc.
Beth Israel Deaconess Medical Center, Inc.
Boston, MA
Other trademarks owned by Beth Israel Deaconess Medical Center, Inc.
Natick, MA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan B. Meyer
Susan B. Meyer Gordon Rees Scully Mansukhani LLP101 West Broadway, Suite 2000San Diego, CA 92101UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Contrast agents for use in surgical and medical imaging and visualization; Fluorescent contrast agents for use in surgical and medical imaging and visualization; Exogenous contrast agents for use in surgical and medical imaging and visualization; Near-infrared contrast agents for use in surgical and medical imaging and visualization; Exogenous near-infrared contrast agents for use in surgical and medical imaging and visualization; Near-infrared contrast agents for use in surgical procedures; Exogenous near-infrared contrast agents for use in surgical procedures; Near-infrared contrast agents for use in medical imaging and visualization; Exogenous near-infrared contrast agents for use in medical imaging and visualization; Near-infrared contrast agents for use in real-time surgical imaging and visualization; Exogenous near-infrared contrast agents for use in real-time surgical imaging and visualization, none of the foregoing being ophthalmic preparations, otorhinolaryngological preparations, or preparations for the treatment of inflammation | ACTIVE | May 23, 2011 |
| 010 | Medical and surgical equipment for use in surgical procedures, namely, cameras and near-infrared cameras, and operating software used therewith, all sold as a unit; Medical and surgical equipment for use in medical procedures, namely, cameras and near-infrared cameras; Medical and surgical equipment for use in medical imaging and visualization, namely, cameras and near-infrared cameras, and operating software used therewith, all sold as a unit; Medical and surgical equipment for use in medical imaging and visualization, namely, visual wavelength imaging cameras, ultraviolet wavelength imaging cameras, radioscintigraphic detection hardware, optical lenses, image detectors, light sources, monitors, and operating software used therewith, all sold as a unit; Medical and surgical equipment for use in medical imaging and visualization, namely, cameras and near-infrared cameras; Medical and surgical equipment for use in real-time surgical imaging and visualization, namely, cameras and near-infrared cameras, and operating software used therewith, all sold as a unit; Medical and surgical equipment for use in real-time surgical imaging and visualization, namely, cameras and near-infrared cameras; Medical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; Surgical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; Real-time medical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; Real-time surgical imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; Oncological imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit; Real-time oncological imaging and visualization systems consisting of imaging apparatus and operating software used therewith, all sold as a unit | ACTIVE | Oct 2, 2009 |
| 016 | [ Tools for use in the instruction of medical imaging and visualization, namely, imaging phantoms in the nature of replications of human or animal body parts or tissue, anatomical replicas of human bodies, anatomical replicas of animal bodies, synthetic organs and tissue for instructional use ] | SECTION 8 - CANCELLED | Sep 29, 2011 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Beth Israel Deaconess Medical Center, Inc.
- Other trademarks owned by Beth Israel Deaconess Medical Center, Inc.
- Other trademarks owned by Beth Israel Deaconess Medical Center, Inc.
- Other trademarks owned by CURADEL, LLC
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 016
- Similar marks named FLARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 19, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 19, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 19, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 19, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 2, 2021 | CCON | COUNTERCLAIM OPP. NO. 999999 | — |
| Mar 2, 2021 | CCON | COUNTERCLAIM OPP. NO. 999999 | — |
| Jan 18, 2021 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| Jan 17, 2021 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Sep 18, 2019 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 18, 2019 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 14, 2017 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Aug 14, 2017 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Aug 14, 2017 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 7, 2017 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 18, 2017 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 18, 2017 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jan 17, 2017 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Jul 20, 2015 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2015 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 24, 2014 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 15, 2012 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 15, 2012 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 17, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 10, 2011 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Dec 9, 2011 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Dec 6, 2011 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Nov 19, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 18, 2011 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Nov 18, 2011 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Nov 8, 2011 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Nov 7, 2011 | IUAF | USE AMENDMENT FILED | — |
| Nov 7, 2011 | EXT2 | SOU EXTENSION 2 FILED | — |
| Nov 7, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 7, 2011 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| May 11, 2011 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 9, 2011 | EX1G | SOU EXTENSION 1 GRANTED | — |
| May 9, 2011 | EXT1 | SOU EXTENSION 1 FILED | — |
| May 9, 2011 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2010 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 17, 2010 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Sep 3, 2010 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Sep 2, 2010 | APET | ASSIGNED TO PETITION STAFF | — |
| Sep 2, 2010 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| May 20, 2010 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| May 4, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 4, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 31, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 31, 2010 | ALIE | ASSIGNED TO LIE | — |
| Mar 17, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2010 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 15, 2010 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 15, 2010 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 13, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 13, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 18, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 18, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 18, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 18, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 18, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2009 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 22, 2008 | NWAP | NEW APPLICATION ENTERED | — |